Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 56% ± 24% | |
lung | 13 studies | 31% ± 15% | |
eye | 8 studies | 43% ± 19% | |
peripheral blood | 5 studies | 27% ± 9% | |
heart | 5 studies | 28% ± 8% | |
liver | 4 studies | 31% ± 12% | |
adipose | 4 studies | 44% ± 23% | |
intestine | 3 studies | 22% ± 6% | |
kidney | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 7021.58 | 245 / 245 | 100% | 343.78 | 502 / 502 |
brain | 99% | 17092.61 | 2622 / 2642 | 100% | 78.32 | 705 / 705 |
intestine | 100% | 2406.82 | 965 / 966 | 99% | 36.04 | 523 / 527 |
breast | 100% | 3869.15 | 459 / 459 | 99% | 53.68 | 1106 / 1118 |
adrenal gland | 100% | 3278.51 | 258 / 258 | 99% | 40.43 | 227 / 230 |
lung | 99% | 2806.18 | 571 / 578 | 99% | 43.68 | 1149 / 1155 |
thymus | 99% | 2225.64 | 646 / 653 | 99% | 35.67 | 600 / 605 |
uterus | 99% | 2212.79 | 168 / 170 | 99% | 34.68 | 455 / 459 |
bladder | 100% | 3173.67 | 21 / 21 | 97% | 35.76 | 491 / 504 |
stomach | 98% | 1892.43 | 351 / 359 | 99% | 36.77 | 282 / 286 |
esophagus | 97% | 1961.88 | 1395 / 1445 | 99% | 43.30 | 182 / 183 |
ovary | 100% | 2500.67 | 180 / 180 | 95% | 24.06 | 410 / 430 |
skin | 100% | 3788.96 | 1806 / 1809 | 89% | 26.54 | 419 / 472 |
kidney | 58% | 882.04 | 52 / 89 | 94% | 25.36 | 848 / 901 |
pancreas | 52% | 683.30 | 169 / 328 | 99% | 45.75 | 176 / 178 |
adipose | 100% | 4048.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 36.03 | 1 / 1 |
muscle | 100% | 3106.71 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 1980.87 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2449.31 | 1323 / 1335 | 0% | 0 | 0 / 0 |
liver | 37% | 482.61 | 83 / 226 | 60% | 9.74 | 242 / 406 |
lymph node | 0% | 0 | 0 / 0 | 86% | 18.44 | 25 / 29 |
peripheral blood | 79% | 2117.25 | 730 / 929 | 0% | 0 | 0 / 0 |
heart | 67% | 1039.29 | 581 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 5.37 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097205 | Biological process | renal filtration |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_1905205 | Biological process | positive regulation of connective tissue replacement |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0008544 | Biological process | epidermis development |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0090193 | Biological process | positive regulation of glomerulus development |
GO_0014898 | Biological process | cardiac muscle hypertrophy in response to stress |
GO_0048813 | Biological process | dendrite morphogenesis |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0051592 | Biological process | response to calcium ion |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0043403 | Biological process | skeletal muscle tissue regeneration |
GO_0045807 | Biological process | positive regulation of endocytosis |
GO_0110062 | Biological process | negative regulation of angiotensin-activated signaling pathway |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0046676 | Biological process | negative regulation of insulin secretion |
GO_0023057 | Biological process | negative regulation of signaling |
GO_0042060 | Biological process | wound healing |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0014883 | Biological process | transition between fast and slow fiber |
GO_0070262 | Biological process | peptidyl-serine dephosphorylation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0033555 | Biological process | multicellular organismal response to stress |
GO_0016311 | Biological process | dephosphorylation |
GO_0006606 | Biological process | protein import into nucleus |
GO_0061006 | Biological process | regulation of cell proliferation involved in kidney morphogenesis |
GO_1905665 | Biological process | positive regulation of calcium ion import across plasma membrane |
GO_0001975 | Biological process | response to amphetamine |
GO_0099170 | Biological process | postsynaptic modulation of chemical synaptic transmission |
GO_0097720 | Biological process | calcineurin-mediated signaling |
GO_0046878 | Biological process | positive regulation of saliva secretion |
GO_0050774 | Biological process | negative regulation of dendrite morphogenesis |
GO_0042110 | Biological process | T cell activation |
GO_0006816 | Biological process | calcium ion transport |
GO_1903244 | Biological process | positive regulation of cardiac muscle hypertrophy in response to stress |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_1905949 | Biological process | negative regulation of calcium ion import across plasma membrane |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0036057 | Cellular component | slit diaphragm |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0030018 | Cellular component | Z disc |
GO_0005739 | Cellular component | mitochondrion |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0019897 | Cellular component | extrinsic component of plasma membrane |
GO_0042383 | Cellular component | sarcolemma |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005955 | Cellular component | calcineurin complex |
GO_0005829 | Cellular component | cytosol |
GO_0008287 | Cellular component | protein serine/threonine phosphatase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0019899 | Molecular function | enzyme binding |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0051117 | Molecular function | ATPase binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_0033192 | Molecular function | calmodulin-dependent protein phosphatase activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0016018 | Molecular function | cyclosporin A binding |
Gene name | PPP3CA |
Protein name | Protein phosphatase 3 catalytic subunit alpha Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) Serine/threonine-protein phosphatase (EC 3.1.3.16) |
Synonyms | CALNA CNA |
Description | FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals . Many of the substrates contain a PxIxIT motif and/or a LxVP motif . In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cofilin dephosphorylation . In response to increased Ca(2+) levels following mitochondrial depolarization, dephosphorylates DNM1L inducing DNM1L translocation to the mitochondrion . Positively regulates the CACNA1B/CAV2.2-mediated Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity). Dephosphorylates heat shock protein HSPB1 (By similarity). Dephosphorylates and activates transcription factor NFATC1 . In response to increased Ca(2+) levels, regulates NFAT-mediated transcription probably by dephosphorylating NFAT and promoting its nuclear translocation . Dephosphorylates and inactivates transcription factor ELK1 . Dephosphorylates DARPP32 . May dephosphorylate CRTC2 at 'Ser-171' resulting in CRTC2 dissociation from 14-3-3 proteins . Dephosphorylates transcription factor TFEB at 'Ser-211' following Coxsackievirus B3 infection, promoting nuclear translocation . Required for postnatal development of the nephrogenic zone and superficial glomeruli in the kidneys, cell cycle homeostasis in the nephrogenic zone, and ultimately normal kidney function (By similarity). Plays a role in intracellular AQP2 processing and localization to the apical membrane in the kidney, may thereby be required for efficient kidney filtration (By similarity). Required for secretion of salivary enzymes amylase, peroxidase, lysozyme and sialic acid via formation of secretory vesicles in the submandibular glands (By similarity). Required for calcineurin activity and homosynaptic depotentiation in the hippocampus (By similarity). Required for normal differentiation and survival of keratinocytes and therefore required for epidermis superstructure formation (By similarity). Positively regulates osteoblastic bone formation, via promotion of osteoblast differentiation (By similarity). Positively regulates osteoclast differentiation, potentially via NFATC1 signaling (By similarity). May play a role in skeletal muscle fiber type specification, potentially via NFATC1 signaling (By similarity). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). Required for antigen-specific T-cell proliferation response (By similarity). Dephosphorylates KLHL3, promoting the interaction between KLHL3 and WNK4 and subsequent degradation of WNK4 . Negatively regulates SLC9A1 activity . . |
Accessions | Q08209 ENST00000394854.8 [Q08209-1] ENST00000512215.5 [Q08209-4] E7ETC2 ENST00000525819.1 A0A0S2Z4B5 A0A0S2Z4C6 ENST00000507176.5 ENST00000492351.6 ENST00000323055.10 [Q08209-3] H0YAB4 E9PK68 ENST00000529324.5 E9PPC8 ENST00000394853.8 [Q08209-2] |